Research location
Lakewood
Ohio, United States
Advertisement
Research activity in Lakewood
Ohio, United StatesCureCurrent currently publishes aggregate city-level research activity for this location: 16 trials and 16 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Lakewood
16 linked trials · page 1 of 1A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus)NCT04777409 · 2021-05-18 · 1 site observation
COMPLETED
A Study of E2027 in Participants With Dementia With Lewy Bodies (DLB) or Parkinson's Disease Dementia (PDD) With or Without Amyloid CopathologyNCT04764669 · 2021-02-25 · 1 site observation
COMPLETED
A 24-Month Study to Evaluate the Efficacy and Safety of Elenbecestat (E2609) in Participants With Early Alzheimer's DiseaseNCT02956486 · 2016-10-20 · 1 site observation
TERMINATED
Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's TypeNCT02446132 · 2015-11-13 · 1 site observation
TERMINATED
Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Participants With Dementia of the Alzheimer's TypeNCT02442778 · 2015-11-11 · 1 site observation
COMPLETED
Rasagiline Rescue in Alzheimer's Disease Clinical TrialNCT02359552 · 2015-05-01 · 1 site observation
COMPLETED
Long-term Safety and Tolerability of Idalopirdine (Lu AE58054) as Adjunctive Treatment to Donepezil in Patients With Mild-moderate Alzheimer's DiseaseNCT02079246 · 2014-04-07 · 1 site observation
COMPLETED
Idalopirdine in Patients With Mild-moderate Alzheimer's Disease Treated With DonepezilNCT02006641 · 2014-02-01 · 1 site observation
COMPLETED
Efficacy, Safety and Tolerability Study of AVP-923 (Dextromethorphan/Quinidine) for Treatment of Symptoms of Agitation in Participants With Alzheimer's DiseaseNCT01584440 · 2012-08-13 · 1 site observation
COMPLETED
Performance of AclarusDx™, a Blood-Based Transcriptomic Test for AD, in US Patients Newly Referred to a Memory CenterNCT01465360 · 2011-11-01 · 1 site observation
COMPLETED
Effect of Ruboxistaurin on Clinically Significant Macular EdemaNCT00133952 · 2005-08-01 · 1 site observation
COMPLETED
GALLEX 6: Study to Evaluate the Safety and Tolerability of Tesaglitazar in Patients With Type 2 Diabetes MellitusNCT00226330 · 2005-03-01 · 1 site observation
TERMINATED
PARTNERS HF: Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart FailureNCT00279955 · 2004-06-01 · 1 site observation
COMPLETED
Clinical Utility and Safety of Pramlintide in Subjects With Type 1 and Type 2 Diabetes MellitusNCT00108004 · 2003-04-01 · 1 site observation
COMPLETED
Demonstrate Exubera Works As Well As Avandia When Added To Sulfonylurea + Metformin In Controlling GlucoseNCT00150410 · 2003-01-01 · 1 site observation
COMPLETED
GLAD: Dose-Finding, Efficacy, and Safety of AZ 242 (Tesaglitazar) in Subjects With Type 2 DiabetesNCT00280865 · 2002-04-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.